Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001387131-19-005254
Filing Date
2019-07-22
Accepted
2019-07-23 09:58:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP stephan-sc13d_071219.htm SC 13D 53594
  Complete submission text file 0001387131-19-005254.txt   55087
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Subject) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-82720 | Film No.: 19966947
SIC: 2834 Pharmaceutical Preparations

Mailing Address 213 SMITHFIELD ST PITTSBURGH PA 15222
Business Address
Stephan Dietrich A (Filed by) CIK: 0001774588 (see all company filings)

Type: SC 13D